The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Biodesix Inc shares valued at $676 were sold by Vazquez Chris on Jan 16 ’26. At $8.15 per share, Vazquez Chris sold 83 shares. The insider’s holdings dropped to 1,072 shares worth approximately $11706.24 following the completion of this transaction.
Also, Pestano Gary Anthony sold 298 shares, netting a total of over 2,428 in proceeds. Following the sale of shares at $8.15 each, the insider now holds 8,446 shares.
Before that, O’Kane Kieran had sold 298 shares from its account. In a trade valued at $2,428, the Chief Commercial Officer traded Biodesix Inc shares for $8.15 each. Upon closing the transaction, the insider’s holdings decreased to 298 shares, worth approximately $85929.48.
As published in a research note from William Blair on May 14, 2025, Biodesix Inc [BDSX] has been rated down from an Outperform to a Mkt perform. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid September. As of July 26, 2024, Craig Hallum has initiated its “Buy” rating for BDSX. Earlier on May 13, 2024, TD Cowen initiated its rating. Their recommendation was “a Buy” for BDSX stock.
Analyzing BDSX Stock Performance
On last trading session, Biodesix Inc [NASDAQ: BDSX] rose 22.42% to $10.92. The stock’s lowest price that day was $8.635, but it reached a high of $11.9 in the same session. During the last five days, there has been a surge of approximately 10.53%. Over the course of the year, Biodesix Inc shares have dropped approximately -52.52%.
Is Biodesix Inc subject to short interest?
Stocks of Biodesix Inc saw a sharp rise in short interest on 2025-12-31 jumping by 5317.0 shares to 80722.0. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 75405.0 shares. A jump of 6.59% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.22 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.22.
Which companies own the most shares of Biodesix Inc (BDSX)?
In terms of Biodesix Inc share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, up nearly 124.22% from the previous closing price of $8.92. Analysts anticipate Biodesix Inc stock to reach 20 by 2026, with the lowest price target being 20. In spite of this, 1 analysts ranked Biodesix Inc stock as Buy at the end of 2026. On May 03, 2024, Lake Street assigned a price target of “a Buy” to the stock and initiated coverage with a $3.
